SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-337226
Filing Date
2017-11-08
Accepted
2017-11-08 16:06:57
Documents
54
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d454395d10q.htm 10-Q 393249
2 EX-31.1 d454395dex311.htm EX-31.1 8978
3 EX-31.2 d454395dex312.htm EX-31.2 8988
4 EX-32.1 d454395dex321.htm EX-32.1 4880
  Complete submission text file 0001193125-17-337226.txt   3271842

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cbay-20170930.xml EX-101.INS 747957
6 XBRL TAXONOMY EXTENSION SCHEMA cbay-20170930.xsd EX-101.SCH 35246
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbay-20170930_cal.xml EX-101.CAL 49891
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbay-20170930_def.xml EX-101.DEF 110725
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20170930_lab.xml EX-101.LAB 296293
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20170930_pre.xml EX-101.PRE 206486
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36500 | Film No.: 171186639
SIC: 2834 Pharmaceutical Preparations